The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Abstract
The "catecholamine hypothesis of affective disorders" proposes that some, if not all, depressions are associated with an absolute or relative decrease in catecholamines, particularly norepinephrine, available at central adrenergic receptor sites. Elation, conversely, may be associated with an excess of such amines. Evidence supporting this hypothesis was reviewed. Data from pharmacological studies, mainly in animals, suggest that the actions of both major classes of antidepressant drugs are mediated through the catecholamines. The monoamine oxidase inhibitors increase brain concentrations of norepinephrine while imipramine-like agents potentiate the physiological effects of norepinephrine. Reserpine, a drug which can cause clinical depression, depletes catecholamines, but other amines may also be involved in its mechanism of action. A rigorous extrapolation from pharmacological studies to pathophysiology clearly cannot be made. Clinical studies relevant to the catecholamime hypothesis are limited and the findings are inconclusive. It is not possible, therefore, to confirm definitively or to reject the catecholamine hypothesis on the basis of data currently available. In our present state of knowledge, however, the catecholamine hypothesis is of considerable heuristic value, providing the investigator and the clinician with a frame of reference integrating much of our experience with those pharmacological agents which produce alterations in human affective states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists
CARLSSON, A., LINDQVIST, M., & MAGNUSSON, T. (1957) · Nature · doi:10.1038/1801200a0 · Cited by 1,278
A CONCEPT FOR A ROLE OF SEROTONIN AND NOREPINEPHRINE AS CHEMICAL MEDIATORS IN THE BRAIN
Brodie, B. B., & Shore, P. A. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40753.x · Cited by 637
POTENTIATION OF THE ANTIDEPRESSIVE EFFECT OF A MONOAMINE-OXIDASE INHIBITOR BY TRYPTOPHAN
Coppen, A., Shaw, D., & Farrell, J. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91084-5 · Cited by 344
Marley, E. (1962) · Psychopharmacologia · doi:10.1007/bf00411372 · Cited by 218
MODIFICATIONS OF THE PHARMACOLOGY OF RESERPINE AND SEROTONIN BY IPRONIAZID
Chessin, M., Kramer, E. R., & Scott, C. C. (1957) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11898-3 · Cited by 112
Achor, R. W. P. (1955) · JAMA · doi:10.1001/jama.1955.02960260011004 · Cited by 91
Potentiation of the behavioral effects of amphetamine by imipramine
Carlton, P. L. (1961) · Psychopharmacology · doi:10.1007/bf00404124 · Cited by 87
BUSFIELD, B. L., WECHSLER, H., & BARNUM, W. J. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710170050006 · Cited by 27
Research works printed but not linked: 10
- 10.1007/978-1-4684-8306-2_14 · doi:10.1007/978-1-4684-8306-2_14
- Axelrod J., 1963, : The Clinical Chemistry of Monoamines.
- 10.1016/S0079-6123(08)60119-3 · doi:10.1016/s0079-6123(08)60119-3
- Bergsman A., 1959, Acta Psychiat. Neurol. Scand. 33:suppl. 133
- Carlsson A., 1961, Neuropsychopharmacology, 2, 417
- 10.1016/S0079-6123(08)60110-7 · doi:10.1016/s0079-6123(08)60110-7
- Carlsson A., 1960, : Adrenergic Mechanisms.
- 10.1007/978-1-4684-8306-2_16 · doi:10.1007/978-1-4684-8306-2_16
- Cole, 1961, J. 0., Jones, R. T., and Kierman, C. L.: Drug Therapy, Progr. Neurol. Psychiat., 16, 539
- Cole, 1960, J. 0., Klerman, G. L., and Jones, R. T.: Drug Therapy, Progr. Neurol. Psychiat., 15, 540
Cited by
Cognitive Therapy for Depression: (675542012-001)
(2012) · PsycEXTRA Dataset · doi:10.1037/e675542012-001 · Cited by 9,663
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Cognitive Therapy of Depression
HOLLON, S. D., & BECK, A. T. (1979) · Cognitive-Behavioral Interventions · doi:10.1016/b978-0-12-404480-7.50012-5 · Cited by 4,685
Gray, J. A. (1982) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00013066 · Cited by 4,477
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
A neuropsychological theory of positive affect and its influence on cognition.
Ashby, F. G., Isen, A. M., & Turken, A. U. (1999) · Psychological Review · doi:10.1037/0033-295x.106.3.529 · Cited by 2,270
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Neurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606
Gold, P. W., & Chrousos, G. P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001032 · Cited by 1,274
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
The Biochemistry of Affective Disorders
Coppen, A. (1967) · British Journal of Psychiatry · doi:10.1192/bjp.113.504.1237 · Cited by 1,230
Norepinephrine in Depressive Reactions: A Review
BUNNEY, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,153
A cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Jouvet, M. (1972) · Neurophysiology and Neurochemistry of Sleep and Wakefulness · doi:10.1007/3-540-05462-6_2 · Cited by 1,098
Clinical and Biochemical Manifestations of Depression
Gold, P. W., Goodwin, F. K., & Chrousos, G. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808183190706 · Cited by 1,053
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
Forced swimming test in mice: A review of antidepressant activity
Petit-Demouliere, B., Chenu, F., & Bourin, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2048-7 · Cited by 1,003
“At this point, a completely new approach was exposed: the monoamine theory of depression or biogenic amine hypothesis (Bunney and Davis 1965; Schildkraut 1965; Coppen 1967).”
BackgroundConsequences of commitment to and disengagement from incentives.
Klinger, E. (1975) · Psychological Review · doi:10.1037/h0076171 · Cited by 969
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933
Schildkraut, J. J., & Kety, S. S. (1967) · Science · doi:10.1126/science.156.3771.21 · Cited by 875
Self-citationAntidepressant-like effect of brain-derived neurotrophic factor (BDNF)
Siuciak, J. A., Lewis, D. R., Wiegand, S. J., & Lindsay, R. M. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00169-4 · Cited by 841
The Brief MAST: A Shortened Version of the Michigan Alcoholism Screening Test
POKORNY, A. D., MILLER, B. A., & KAPLAN, H. B. (1972) · American Journal of Psychiatry · doi:10.1176/ajp.129.3.342 · Cited by 839
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767
Animal Model of Depression: I. Review of Evidence: Implications for Research
McKinney, W. T. (1969) · Archives of General Psychiatry · doi:10.1001/archpsyc.1969.01740200112015 · Cited by 727
Development of β-adrenergic receptor subsensitivity by antidepressants
BANERJEE, S. P., KUNG, L. S., RIGGI, S. J., & CHANDA, S. K. (1977) · Nature · doi:10.1038/268455a0 · Cited by 722
Bymaster, F. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00298-6 · Cited by 717
Lapin, I. P., & Oxenkrug, G. F. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91140-4 · Cited by 709
"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?
Åsberg, M., Thorén, P., Traskman, L., Bertilsson, L., & Ringberger, V. (1976) · Science · doi:10.1126/science.1246632 · Cited by 682
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
The olfactory bulbectomized rat as a model of depression: An update
Kelly, J. P., Wrynn, A. S., & Leonard, B. E. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)00004-1 · Cited by 662
Charney, D. S. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780350094011 · Cited by 649
Deacon, B. J. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.09.007 · Cited by 643
Sensation seeking: A comparative approach to a human trait
Zuckerman, M. (1984) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00018938 · Cited by 633
Mueser, K. T., Drake, R. E., & Wallach, M. A. (1998) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00073-2 · Cited by 617
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
Vulnerability to psychopathology: A biosocial model.
Zuckerman, M. (1999) · American Psychological Association eBooks · doi:10.1037/10316-000 · Cited by 601
Ashok, A. H., Marques, T. R., Jauhar, S., Nour, M. M., Goodwin, G. M., Young, A. H., & Howes, O. D. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.16 · Cited by 546
Auer, D. P., Pütz, B., Kraft, E., Lipinski, B., Schill, J., & Holsboer, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00159-6 · Cited by 564
Castrén, E. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1629 · Cited by 563
EFFECTS OF THYROTROPIN-RELEASING HORMONE IN DEPRESSION*1
PRANGE, A. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92407-5 · Cited by 557
Reduced Corticotropin Releasing Factor Binding Sites in the Frontal Cortex of Suicide Victims
Nemeroff, C. B. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800300075009 · Cited by 555
Increased Serotonin2 and β-Adrenergic Receptor Binding in the Frontal Cortices of Suicide Victims
Mann, J. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800100048007 · Cited by 547
Clinical and Biochemical Manifestations of Depression
Gold, P. W., Goodwin, F. K., & Chrousos, G. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808113190606 · Cited by 547
Akiskal, H. S. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760210019001 · Cited by 546
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535
Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment
Kanner, A. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00469-4 · Cited by 525
Overview: toward a dysregulation hypothesis of depression
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.9.1017 · Cited by 518
Mode of action of antidepressant drugs
Sulser, F., Vetulani, J., & Mobley, P. L. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90226-5 · Cited by 515
Central monoamines and their role in major depression
Elhwuegi, A. S. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.11.018 · Cited by 504
Lithium in psychiatric therapy and prophylaxis
Schou, M. (1968) · Journal of Psychiatric Research · doi:10.1016/0022-3956(68)90047-2 · Cited by 501
Lopez-Munoz, F., & Alamo, C. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168001 · Cited by 476
Circuits and functions of the lateral habenula in health and in disease
Hu, H., Cui, Y., & Yang, Y. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0292-4 · Cited by 476
Classification of suicidal behaviors: I. Quantifying intent and medical lethality
(1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.3.285 · Cited by 460
Veith, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050071008 · Cited by 460
Banasr, M., Chowdhury, G. M. I., Terwilliger, R., Newton, S. S., Duman, R. S., Behar, K. L., & Sanacora, G. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.106 · Cited by 458
Mood change following left hemispheric brain injury
Robinson, R. G., & Szetela, B. (1981) · Annals of Neurology · doi:10.1002/ana.410090506 · Cited by 455
Potential Mechanisms of Action of Lithium in Bipolar Disorder: Current Understanding
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0039-0 · Cited by 453
Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression
Klimek, V., Stockmeier, C., Overholser, J., Meltzer, H. Y., Kalka, S., Dilley, G., & Ordway, G. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08451.1997 · Cited by 445
The effects of chronic antidepressant treatment in an animal model of anxiety
Bodnoff, S., Suranyi-Cadotte, B., Aitken, D., Quirion, R., & Meaney, M. (1988) · Psychopharmacology · doi:10.1007/bf00181937 · Cited by 437
“A considerable literature exists on the effects of antidepressants upon various central monoaminergic systems ( Schildkraut 1965; Sulser et al. 1978; Charney et al. 1981).”
BackgroundDepression: The predisposing influence of stress
Anisman, H., & Zacharko, R. M. (1982) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00010633 · Cited by 432
Stuck in a rut: rethinking depression and its treatment
Holtzheimer, P. E., & Mayberg, H. S. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 430
Development and self-regulatory structures of the mind
Cicchetti, D., & Tucker, D. (1994) · Development and Psychopathology · doi:10.1017/s0954579400004673 · Cited by 429
Animal models of depression: An overview
Willner, P. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90076-e · Cited by 428
The Discovery of Fluoxetine Hydrochloride (Prozac)
Wong, D. T., Perry, K. W., & Bymaster, F. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1821 · Cited by 418
Maes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R., & Meltzer, H. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00092-5 · Cited by 417
Vetulani, J., Stawarz, R. J., Dingell, J. V., & Sulser, F. (1976) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00499215 · Cited by 413
Meltzer, P. C., Butler, D., Deschamps, J. R., & Madras, B. K. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050797a · Cited by 411
Blood platelets as a model for monoamine-containing neurones
Sneddon, J. M. (1973) · Progress in Neurobiology · doi:10.1016/0301-0082(73)90019-1 · Cited by 404
Sullivan, P. F., de Geus, E. J. C., Willemsen, G., James, M. R., Smit, J. H., Zandbelt, T., Arolt, V, Baune, B. T., Blackwood, D., Cichon, S., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.125 · Cited by 404
Akiskal, H. S., & McKinney, W. T. (1973) · Science · doi:10.1126/science.182.4107.20 · Cited by 389
Mongeau, R., Blier, P., & de Montigny, C. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00017-3 · Cited by 389
Enhancement of Imipramine Antidepressant Activity by Thyroid Hormone
PRANGE, A. J., WILSON, I. C., RABON, A. M., & LIPTON, M. A. (1969) · American Journal of Psychiatry · doi:10.1176/ajp.126.4.457 · Cited by 388
Schlesser, M. A. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780200015001 · Cited by 387
Wang, Y.-M., Gainetdinov, R. R., Fumagalli, F., Xu, F., Jones, S. R., Bock, C. B., Miller, G. W., Wightman, R. M., & Caron, M. G. (1997) · Neuron · doi:10.1016/s0896-6273(00)80419-5 · Cited by 376
Jesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
Animal models of major depression and their clinical implications
Czéh, B., Fuchs, E., Wiborg, O., & Simon, M. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.04.004 · Cited by 375
The Flinders sensitive line rats: a genetic animal model of depression
Overstreet, D. H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80230-1 · Cited by 369
Depression and epilepsy: How closely related are they?
Kanner, A. M., & Balabanov, A. (2002) · Neurology · doi:10.1212/wnl.58.8_suppl_5.s27 · Cited by 367
Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106069938 · Cited by 366
Neurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
The Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365
Maas, J. W. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760290025002 · Cited by 364
Brown, A. S., & Gershon, S. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245227 · Cited by 357
Maes, M., Smith, R., Christophe, A., Vandoolaeghe, E., Gastel, A. V., Neels, H., Demedts, P., Wauters, A., & Meltzer, H. Y. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09622.x · Cited by 356
Biochemistry of tryptophan in health and disease
Bender, D. A. (1983) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(83)90005-5 · Cited by 355
Estrogen Therapy for Severe Persistent Depressions in Women
Klaiber, E. L. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050060006 · Cited by 353
Role of the dopaminergic system in depression
Kapur, S., & John Mann, J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90137-o · Cited by 348
Jayatissa, M. N., Bisgaard, C., Tingström, A., Papp, M., & Wiborg, O. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301041 · Cited by 348
Hellemans, K. G. C., Sliwowska, J. H., Verma, P., & Weinberg, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.004 · Cited by 347
Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Allen, J., Romay-Tallon, R., Brymer, K. J., Caruncho, H. J., & Kalynchuk, L. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00386 · Cited by 347
A Hypothesis of Thyroid-Catecholamine-Receptor Interaction: Its Relevance to Affective Illness
Whybrow, P. C. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260108012 · Cited by 344
Catecholamine Metabolism, Depressive Illness, and Drug Response
Maas, J. W. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750210060012 · Cited by 342
Serotonin and brain development
Sodhi, M. S. K., & Sanders-Bush, E. (2004) · International Review of Neurobiology · doi:10.1016/s0074-7742(04)59006-2 · Cited by 340
Reduced Monoamine Oxidase Activity in Blood Platelets from Bipolar Depressed Patients
MURPHY, D. L., & WEISS, R. (1972) · American Journal of Psychiatry · doi:10.1176/ajp.128.11.1351 · Cited by 335
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
Wong, E. H. F., Sonders, M. S., Amara, S. G., Tinholt, P. M., Piercey, M. F. P., Hoffmann, W. P., Hyslop, D. K., Franklin, S., Porsolt, R. D., Bonsignori, A., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00291-7 · Cited by 334
Metadata
- Authors
- SCHILDKRAUT, J. J.
- Venue
- American Journal of Psychiatry
- Published
- 1965-11
- Volume
- 122
- Issue
- 5
- Pages
- 509-522
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2072219714
- Cited by
- 3,492
- References
- 8
- FWCI
- 39.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.